Indivior Pharmaceuticals Inc Ordinary Share Earnings & Forecasts

Indivior Pharmaceuticals Inc Ordinary Share (INDV) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	Oct 29, 2026	$1.32	$1.08	22.2 %
Q2	Aug 3, 2026	$1.15	$0.92	25.0 %
Q1	Apr 30, 2026	$0.96	$0.66	45.5 %
Q4	Feb 26, 2026	$0.82	$0.66	24.2 %

Quarterly Revenue (Billions)

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Oct 29, 2026	$356.00M	$328.82M	8.27 %
Q2	Aug 3, 2026	$343.00M	$306.84M	11.8 %
Q1	Apr 30, 2026	$317.00M	$272.00M	16.5 %
Q4	Feb 26, 2026	$358.00M	$305.46M	17.2 %

Indivior Pharmaceuticals Inc Ordinary Share Guidance

Indivior Pharmaceuticals Inc Ordinary Share (INDV) last issued guidance on October 29, 2026 for fiscal year 2026. The company guided revenue in the range of $1.29B - $1.36B for the period.

Compared to prior guidance, Indivior Pharmaceuticals Inc Ordinary Share maintained its revenue forecast from a prior range of $1.29B - $1.36B.

Indivior Pharmaceuticals Inc Ordinary Share has issued 18 guidance updates between October 23, 2023 and October 29, 2026. During this period, the company raised its outlook 5 times and lowered it 6 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q3 '26	Q2 '26	Q1 '26	Q4 '25
Earnings Per Share (Non-GAAP)
Estimate	$1.08	$0.92	$0.66	$0.66
Actual	$1.32	$1.15	$0.96	$0.82
Surprise	+22.2%	+25.0%	+45.5%	+24.2%
Revenue
Estimate	$328.8M	$306.8M	$272.0M	$305.5M
Actual	$356.0M	$343.0M	$317.0M	$358.0M
Surprise	+8.27%	+11.8%	+16.5%	+17.2%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q4 '26E	Q1 '27E
Earnings Per Share (Non-GAAP)
Consensus	$1.19	$0.95
Revenue
Consensus	$336.6M	$328.0M